Triomics, which is building an AI-powered platform to help oncologists automate data-heavy tasks, raised a $22M Series B, following a $15M Series A in 2024 (Marina Temkin/TechCrunch)

May 30, 2026 - 04:26
Updated: 2 months ago
0 4
Triomics logo. The company raised $22M Series B for its AI oncology platform.

Marina Temkin / TechCrunch:
Triomics, which is building an AI-powered platform to help oncologists automate data-heavy tasks, raised a $22M Series B, following a $15M Series A in 2024  —  Triomics, a startup building an AI-powered platform to help oncologists and administrative staff automate data-heavy tasks …

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
Christopher Holloway

Christopher Holloway is the founder and director of Progressive Robot, a UK-based technology company. A full-stack engineer with more than two decades of experience, he works across PHP development, ecommerce, Linux infrastructure, technical SEO and AI automation, and writes here on technology, AI, hardware and software.

Comments (0)

User